Vivimed Labs Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | (19) | 8.64 | (2.50) | 2.17 |
| Op profit growth | (47) | 73.40 | 7.01 | 5.77 |
| EBIT growth | (53) | 94.10 | 15.90 | 6.40 |
| Net profit growth | (64) | 156 | 16.10 | 8.52 |
| Profitability ratios (%) | ||||
| OPM | 17.90 | 27.50 | 17.20 | 15.70 |
| EBIT margin | 13.90 | 24.10 | 13.50 | 11.30 |
| Net profit margin | 6.57 | 14.60 | 6.22 | 5.22 |
| RoCE | 8.68 | 21.40 | 11.60 | 10.20 |
| RoNW | 1.99 | 8.11 | 3.66 | 3.22 |
| RoA | 1.02 | 3.25 | 1.34 | 1.18 |
| Per share ratios () | ||||
| EPS | 9.22 | 26.40 | 51.60 | 44.50 |
| Dividend per share | 0.40 | 0.40 | -- | -- |
| Cash EPS | 2.61 | 19.20 | 13.70 | 3.62 |
| Book value per share | 149 | 90.60 | 361 | 345 |
| Valuation ratios | ||||
| P/E | 7.71 | 4.03 | 1.61 | 1.65 |
| P/CEPS | 27.20 | 5.54 | 6.05 | 20.30 |
| P/B | 0.65 | 1.17 | 0.26 | 0.24 |
| EV/EBIDTA | 5.92 | 4.43 | 6.56 | 7.10 |
| Payout (%) | ||||
| Dividend payout | 4.24 | 1.53 | -- | -- |
| Tax payout | (11) | (25) | (16) | (7.10) |
| Liquidity ratios | ||||
| Debtor days | 73.20 | 65.70 | 88.90 | 89.60 |
| Inventory days | 158 | 123 | 127 | 116 |
| Creditor days | (71) | (59) | (58) | (59) |
| Leverage ratios | ||||
| Interest coverage | (2.10) | (5.30) | (2.20) | (2) |
| Net debt / equity | 0.59 | 1.30 | 1.57 | 1.76 |
| Net debt / op. profit | 3.42 | 2.37 | 3.96 | 4.54 |
| Cost breakup () | ||||
| Material costs | (40) | (37) | (46) | (47) |
| Employee costs | (17) | (13) | (13) | (13) |
| Other costs | (25) | (23) | (23) | (24) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Revenue | 1,186 | 1,462 | 1,346 | 1,380 |
| yoy growth (%) | (19) | 8.64 | (2.50) | 2.17 |
| Raw materials | (480) | (536) | (624) | (646) |
| As % of sales | 40.50 | 36.70 | 46.40 | 46.80 |
| Employee costs | (198) | (190) | (177) | (184) |
| As % of sales | 16.70 | 13 | 13.10 | 13.40 |
| Other costs | (296) | (333) | (313) | (333) |
| As % of sales | 25 | 22.80 | 23.20 | 24.10 |
| Operating profit | 212 | 403 | 232 | 217 |
| OPM | 17.90 | 27.50 | 17.20 | 15.70 |
| Depreciation | (56) | (58) | (61) | (66) |
| Interest expense | (79) | (66) | (82) | (79) |
| Other income | 9.61 | 8.09 | 10.80 | 5.87 |
| Profit before tax | 85.70 | 286 | 99.90 | 77.50 |
| Taxes | (9.60) | (73) | (16) | (5.50) |
| Tax rate | (11) | (25) | (16) | (7.10) |
| Minorities and other | 1.85 | -- | -- | -- |
| Adj. profit | 77.90 | 214 | 83.70 | 72 |
| Exceptional items | -- | -- | -- | -- |
| Net profit | 77.90 | 214 | 83.70 | 72.10 |
| yoy growth (%) | (64) | 156 | 16.10 | 8.52 |
| NPM | 6.57 | 14.60 | 6.22 | 5.22 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Profit before tax | 85.70 | 286 | 99.90 | 77.50 |
| Depreciation | (56) | (58) | (61) | (66) |
| Tax paid | (9.60) | (73) | (16) | (5.50) |
| Working capital | 743 | 398 | 356 | 19.10 |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 763 | 554 | 378 | 25 |
| Capital expenditure | 821 | (252) | 334 | 73.10 |
| Free cash flow | 1,584 | 302 | 712 | 98.10 |
| Equity raised | 1,328 | 709 | 851 | 887 |
| Investments | 2.70 | 2.01 | 2.45 | 2.46 |
| Debt financing/disposal | 867 | 593 | 504 | 200 |
| Dividends paid | 3.30 | 3.28 | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 3,785 | 1,609 | 2,069 | 1,188 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Equity capital | 16.50 | 16.50 | 16.20 | 16.20 |
| Preference capital | 325 | 325 | -- | 64 |
| Reserves | 602 | 885 | 718 | 505 |
| Net worth | 944 | 1,226 | 734 | 585 |
| Minority interest | ||||
| Debt | 955 | 824 | 1,011 | 951 |
| Deferred tax liabilities (net) | -- | -- | -- | 10.70 |
| Total liabilities | 1,899 | 2,063 | 1,745 | 1,547 |
| Fixed assets | 1,087 | 1,101 | 955 | 908 |
| Intangible assets | ||||
| Investments | 2.51 | 2.70 | 2.71 | 2.69 |
| Deferred tax asset (net) | 6.79 | 7.86 | 6.46 | -- |
| Net working capital | 707 | 852 | 725 | 605 |
| Inventories | 564 | 540 | 484 | 502 |
| Inventory Days | -- | 166 | 121 | 136 |
| Sundry debtors | 356 | 275 | 200 | 326 |
| Debtor days | -- | 84.80 | 50 | 88.50 |
| Other current assets | 218 | 368 | 358 | 285 |
| Sundry creditors | (294) | (202) | (179) | (167) |
| Creditor days | -- | 62.20 | 44.60 | 45.20 |
| Other current liabilities | (136) | (129) | (138) | (341) |
| Cash | 95.30 | 99 | 55.50 | 31 |
| Total assets | 1,899 | 2,063 | 1,745 | 1,547 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Sep-2020 | Jun-2020 | Mar-2020 | Dec-2019 | Sep-2019 |
|---|---|---|---|---|---|
| Gross Sales | 222 | 323 | 236 | 198 | 281 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 222 | 323 | 236 | 198 | 281 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 1.89 | 1.81 | 2.42 | 2.09 | 2.48 |
| Total Income | 224 | 325 | 238 | 200 | 284 |
| Total Expenditure ** | 206 | 216 | 256 | 207 | 285 |
| PBIDT | 17.30 | 108 | (18) | (6.80) | (1) |
| Interest | 13.70 | 14.90 | 14.70 | 16.50 | 15.60 |
| PBDT | 3.64 | 93.50 | (33) | (23) | (17) |
| Depreciation | 17.60 | 17.30 | 17.50 | 15.60 | 16.90 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | (0.30) | 3.38 | 11.80 | (3.70) | (7.50) |
| Deferred Tax | -- | -- | (1.40) | (3.10) | 0.36 |
| Reported Profit After Tax | (14) | 72.80 | (61) | (32) | (26) |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | (14) | 72.80 | (61) | (32) | (26) |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | (14) | 72.80 | (61) | (32) | (26) |
| EPS (Unit Curr.) | (1.60) | 8.78 | (7.30) | (3.90) | (3.20) |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 7.80 | 33.60 | (7.70) | (3.40) | (0.40) |
| PBDTM(%) | 1.64 | 29 | (14) | (12) | (5.90) |
| PATM(%) | (6.10) | 22.60 | (26) | (16) | (9.40) |
